Related Experiment Video
Updated: Jun 28, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Association of serotonin transporter gene polymorphisms with poststroke depression
Ruth Kohen1, Kevin C Cain, Pamela H Mitchell
1Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle,WA 98108, USA. ruko@u.washington.edu
Context:
Polymorphisms of the serotonin transporter gene (SERT) have been associated with mental illness. In people with long-term medical conditions, variants of the 5-HTTLPR and STin2 VNTR polymorphisms of SERT have been shown to confer a heightened vulnerability to comorbid depression.
Objective:
To determine whether the 5-HTTLPR, STin2 VNTR, and rs25531 polymorphisms of SERT are associated with poststroke depression (PSD) in stroke survivors.
Design:
A case-control study in which stroke survivors were screened for depressive symptoms and assigned to either a depressed group or a nondepressed group.
Setting:
Outpatient clinic.
Participants:
Seventy-five stroke survivors with PSD and 75 nondepressed stroke survivors.
Interventions:
Blood or saliva samples were collected from each participant for DNA extraction and genotyping.
Main Outcome Measures:
The associations between the 5-HTTLPR, STin2 VNTR, and rs25531 polymorphisms and PSD.
Results:
Individuals with the 5-HTTLPR s/s genotype had 3-fold higher odds of PSD compared with l/l or l/xl genotype carriers (odds ratio, 3.1; 95% confidence interval, 1.2-8.3). Participants with the STin2 9/12 or 12/12 genotype had 4-fold higher odds of PSD compared with STin2 10/10 genotype carriers (odds ratio, 4.1; 95% confidence interval, 1.2-13.6). An association of rs25531 with PSD was not shown.
Conclusions:
The 5-HTTLPR and the STin2 VNTR, but not the rs25531, polymorphisms of SERT are associated with PSD in stroke survivors. This gives further evidence of a role of SERT polymorphisms in mediating resilience to biopsychosocial stress.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Antidepressant Drugs: MAOIs and Other Agents
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
